Humasis Co. Ltd. (KOSDAQ:205470)
842.00
-74.00 (-8.08%)
At close: Feb 20, 2026
Humasis Market Cap
Humasis has a market cap or net worth of 95.28 billion as of February 20, 2026. Its market cap has decreased by -52.46% in one year.
Market Cap
95.28B
Enterprise Value
-58.39B
Revenue
35.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
842.00
Market Cap Chart
Since September 27, 2017, Humasis's market cap has increased from 10.76B to 95.28B, an increase of 785.19%. That is a compound annual growth rate of 29.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 95.28B | -16.96% |
| Dec 30, 2025 | 114.74B | -38.06% |
| Dec 30, 2024 | 185.23B | -22.80% |
| Dec 28, 2023 | 239.92B | -47.44% |
| Dec 29, 2022 | 456.45B | -20.07% |
| Dec 30, 2021 | 571.04B | 75.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.36T |
| Celltrion | 53.52T |
| ALTEOGEN | 22.01T |
| Sam Chun Dang Pharm. | 14.86T |
| CG Invites | 99.19B |
| Oncocross | 96.90B |
| Kukje Pharma | 93.36B |
| Amicogen | 90.84B |